Clinuvel Pharmaceuticals Dividends and Buybacks
Dividend criteria checks 0/6
Clinuvel Pharmaceuticals is a dividend paying company with a current yield of 0.37%.
Key information
0.4%
Dividend yield
0.1%
Buyback Yield
| Total Shareholder Yield | 0.5% |
| Future Dividend Yield | 0.9% |
| Dividend Growth | 24.1% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | AU$0.050 |
| Payout ratio | 7% |
Recent dividend and buyback updates
Recent updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: CUV is not paying a notable dividend for the Australian market, therefore no need to check if payments are stable.
Growing Dividend: CUV is not paying a notable dividend for the Australian market, therefore no need to check if payments are increasing.
Dividend Yield vs Market
| Clinuvel Pharmaceuticals Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (CUV) | 0.4% |
| Market Bottom 25% (AU) | 2.6% |
| Market Top 25% (AU) | 6.0% |
| Industry Average (Biotechs) | 2.3% |
| Analyst forecast (CUV) (up to 3 years) | 0.9% |
Notable Dividend: CUV's dividend (0.37%) isn’t notable compared to the bottom 25% of dividend payers in the Australian market (2.65%).
High Dividend: CUV's dividend (0.37%) is low compared to the top 25% of dividend payers in the Australian market (6.07%).
Earnings Payout to Shareholders
Earnings Coverage: CUV is not paying a notable dividend for the Australian market.
Cash Payout to Shareholders
Cash Flow Coverage: CUV is not paying a notable dividend for the Australian market.